Extraordinary meeting of the Committee for Medicinal Products for Human Use (CHMP): 12 January 2021

Date: 12/01/2021
Location: Virtual meeting

This extraordinary meeting is planned in the context of the evaluation of the COVID-19 vaccine mRNA-1273 developed by Moderna.

The aim of the meeting will be to conclude the evaluation, if this is not possible at the CHMP’s extraordinary meeting on 6 January.

The Committee for Medicinal Products for Human Use (CHMP) is the committee that is responsible for preparing the Agency's opinions on all questions concerning human medicines.

How useful was this page?

Add your rating